Experienced medical oncologist and hematologist joins Bradenton Cancer Center to help meet the growing need for high-quality, community-based cancer care.
FORT MYERS, Fla., Nov. 16, 2026 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) welcomes Vinod Kumar, MD, medical oncologist and hematologist, to the statewide practice. Dr. Kumar provides comprehensive medical oncology and hematology services for patients at Bradenton Cancer Center, located at 3630 Manatee Ave. W., Bradenton, FL 34205, serving Manatee County and surrounding communities.
David Wenk, MD, FCS assistant managing physician, said, "Dr. Kumar brings broad experience in medical oncology and hematology, with special interests in lymphoma, leukemia, multiple myeloma and bone marrow disorders. His dedication to compassionate, personalized care will be a valuable addition to our team and to the patients we serve in the Bradenton community."
Dr. Kumar earned his medical degree from Liaquat University of Health and Medical Sciences in Sukkur, Sindh, Pakistan. He completed his residency in internal medicine at Saint Joseph University Hospital in Paterson, New Jersey, followed by a fellowship in hematology and oncology at the same institution. He went on to complete a fellowship in bone marrow transplant and cellular therapy at Mayo Clinic in Jacksonville, Florida. Dr. Kumar is board certified in internal medicine, oncology and hematology.
As a medical oncologist and hematologist, Dr. Kumar provides care for patients with solid tumors, blood cancers and nonmalignant blood disorders. He has a special interest in lymphoma, leukemia, multiple myeloma and bone marrow disorders, supported by additional training in bone marrow transplant and cellular therapy. He has contributed to multiple research publications in hematology, oncology and internal medicine.
Dr. Kumar takes pride in serving patients. He works closely with patients and multidisciplinary care teams to develop individualized treatment plans based on each patient's diagnosis, needs and goals. He is committed to compassionate, patient-centered care and to helping patients access high-quality cancer treatment close to home.
Patients may call (941) 792-1881 to schedule an appointment with Dr. Kumar at the Bradenton Cancer Center.
About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)
For more than 40 years, Florida Cancer Specialists & Research Institute (FCS) has embraced innovation to deliver world-class care and drive the dramatic transformation of oncology care through its robust clinical research program.
FCS provides patients with access to a wide range of clinical trials, positioning it as a leader in research among private oncology practices in Florida and across the country. Through its robust clinical research program with Sarah Cannon Research Institute (SCRI) and a suite of independent site management programs, with advanced clinical trial matching technology, FCS offers patients innovative therapies close to home. Each year, FCS conducts more than 180 active clinical trials that directly elevate patient care and accelerate progress in oncology. Many of the cancer drugs approved by the FDA in the U.S over the past decade were accessible to patients at FCS through clinical trial participation before receiving approval.
Our outstanding team of highly trained and dedicated physicians is committed to delivering tailored treatment plans that make the best use of cutting-edge precision oncology advancements to enhance patient outcomes.
SOURCE Florida Cancer Specialists & Research Institute

Share this article